Eurofins Scientific SE (ERF.PA)
EUR 56.58
(1.98%)
EUR 56.58
(1.98%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 620.4 Million EUR | -86.17% |
| 2022 | 4.48 Billion EUR | -1.81% |
| 2021 | 4.56 Billion EUR | 23.77% |
| 2020 | 3.69 Billion EUR | 20.63% |
| 2019 | 3.05 Billion EUR | 25.79% |
| 2018 | 2.43 Billion EUR | 27.54% |
| 2017 | 1.9 Billion EUR | 16.35% |
| 2016 | 1.63 Billion EUR | 29.58% |
| 2015 | 1.26 Billion EUR | 37.97% |
| 2014 | 916.8 Million EUR | 16.34% |
| 2013 | 788.04 Million EUR | 17.32% |
| 2012 | 671.7 Million EUR | 25.63% |
| 2011 | 534.69 Million EUR | 25.29% |
| 2010 | 426.75 Million EUR | 9.61% |
| 2009 | 389.32 Million EUR | 2.14% |
| 2008 | 381.15 Million EUR | 31.69% |
| 2007 | 289.42 Million EUR | 31.51% |
| 2006 | 220.08 Million EUR | 47.05% |
| 2005 | 149.66 Million EUR | 31.58% |
| 2004 | 113.74 Million EUR | 9.56% |
| 2003 | 103.81 Million EUR | 9.29% |
| 2002 | 94.99 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 378.3 Million EUR | 0.0% |
| 2024 Q1 | 378.3 Million EUR | 35.16% |
| 2023 Q1 | 319.8 Million EUR | 10.12% |
| 2023 Q3 | 367.55 Million EUR | 37.71% |
| 2023 Q2 | 266.9 Million EUR | -16.54% |
| 2023 Q4 | 279.9 Million EUR | -23.85% |
| 2023 FY | 620.4 Million EUR | -86.17% |
| 2022 Q3 | 341.9 Million EUR | -30.62% |
| 2022 Q4 | 290.4 Million EUR | -15.06% |
| 2022 FY | 4.48 Billion EUR | -1.81% |
| 2022 Q1 | 414.55 Million EUR | -23.2% |
| 2022 Q2 | 492.8 Million EUR | 18.88% |
| 2021 Q4 | 539.8 Million EUR | 20.81% |
| 2021 Q2 | 729.8 Million EUR | 44.79% |
| 2021 Q1 | 504.05 Million EUR | -16.31% |
| 2021 FY | 4.56 Billion EUR | 23.77% |
| 2021 Q3 | 446.8 Million EUR | -38.78% |
| 2020 FY | 3.69 Billion EUR | 20.63% |
| 2020 Q1 | 246.75 Million EUR | 5.25% |
| 2020 Q3 | 459.6 Million EUR | 126.18% |
| 2020 Q2 | 203.2 Million EUR | -17.65% |
| 2020 Q4 | 602.3 Million EUR | 31.05% |
| 2019 FY | 3.05 Billion EUR | 25.79% |
| 2019 Q1 | 207.45 Million EUR | 3.89% |
| 2019 Q2 | 132.15 Million EUR | -36.3% |
| 2019 Q3 | 257.95 Million EUR | 95.19% |
| 2019 Q4 | 234.44 Million EUR | -9.11% |
| 2018 Q1 | 160.17 Million EUR | 4.48% |
| 2018 FY | 2.43 Billion EUR | 27.54% |
| 2018 Q2 | 160.17 Million EUR | 0.0% |
| 2018 Q3 | 199.67 Million EUR | 24.66% |
| 2018 Q4 | 199.67 Million EUR | 0.0% |
| 2017 Q3 | 153.31 Million EUR | 22.6% |
| 2017 FY | 1.9 Billion EUR | 16.35% |
| 2017 Q4 | 153.31 Million EUR | 0.0% |
| 2017 Q1 | 125.04 Million EUR | -4.92% |
| 2017 Q2 | 125.04 Million EUR | 0.0% |
| 2016 Q2 | 108.29 Million EUR | 0.0% |
| 2016 Q1 | 108.29 Million EUR | -0.92% |
| 2016 Q3 | 131.51 Million EUR | 21.45% |
| 2016 Q4 | 131.51 Million EUR | 0.0% |
| 2016 FY | 1.63 Billion EUR | 29.58% |
| 2015 Q1 | 71.1 Million EUR | -6.09% |
| 2015 Q4 | 109.29 Million EUR | 0.0% |
| 2015 Q3 | 109.29 Million EUR | 53.7% |
| 2015 FY | 1.26 Billion EUR | 37.97% |
| 2015 Q2 | 71.1 Million EUR | 0.0% |
| 2014 FY | 916.8 Million EUR | 16.34% |
| 2014 Q3 | 75.71 Million EUR | 38.93% |
| 2014 Q1 | 54.49 Million EUR | -2.39% |
| 2014 Q2 | 54.49 Million EUR | 0.0% |
| 2014 Q4 | 75.71 Million EUR | 0.0% |
| 2013 Q1 | 46.54 Million EUR | -7.94% |
| 2013 FY | 788.04 Million EUR | 17.32% |
| 2013 Q4 | 55.83 Million EUR | 0.0% |
| 2013 Q3 | 55.83 Million EUR | 19.96% |
| 2013 Q2 | 46.54 Million EUR | 0.0% |
| 2012 Q2 | - EUR | -100.0% |
| 2012 Q4 | 50.55 Million EUR | 0.0% |
| 2012 Q3 | 50.55 Million EUR | 0.0% |
| 2012 FY | 671.7 Million EUR | 25.63% |
| 2012 Q1 | 167.92 Million EUR | 6.66% |
| 2011 Q3 | 140.19 Million EUR | 3.91% |
| 2011 Q2 | 134.91 Million EUR | 32.1% |
| 2011 Q1 | 102.13 Million EUR | -79.77% |
| 2011 FY | 534.69 Million EUR | 25.29% |
| 2011 Q4 | 157.44 Million EUR | 12.3% |
| 2010 FY | 426.75 Million EUR | 9.61% |
| 2010 Q2 | 106.71 Million EUR | 18.39% |
| 2010 Q1 | 90.13 Million EUR | -68.68% |
| 2010 Q3 | 308.75 Million EUR | 189.33% |
| 2010 Q4 | 504.91 Million EUR | 63.53% |
| 2009 Q3 | 284.93 Million EUR | 201.11% |
| 2009 Q1 | 88.79 Million EUR | -6.82% |
| 2009 Q4 | 287.81 Million EUR | 1.01% |
| 2009 Q2 | 94.63 Million EUR | 6.57% |
| 2009 FY | 389.32 Million EUR | 2.14% |
| 2008 Q4 | 95.28 Million EUR | 0.0% |
| 2008 FY | 381.15 Million EUR | 31.69% |
| 2008 Q2 | 95.28 Million EUR | 0.0% |
| 2008 Q1 | 95.28 Million EUR | 31.69% |
| 2008 Q3 | 95.28 Million EUR | 0.0% |
| 2007 Q2 | 72.35 Million EUR | 0.0% |
| 2007 Q1 | 72.35 Million EUR | 31.51% |
| 2007 FY | 289.42 Million EUR | 31.51% |
| 2007 Q4 | 72.35 Million EUR | 0.0% |
| 2007 Q3 | 72.35 Million EUR | 0.0% |
| 2006 Q4 | 55.02 Million EUR | 0.0% |
| 2006 FY | 220.08 Million EUR | 47.05% |
| 2006 Q2 | 55.02 Million EUR | 0.0% |
| 2006 Q1 | 55.02 Million EUR | 47.05% |
| 2006 Q3 | 55.02 Million EUR | 0.0% |
| 2005 Q2 | 37.41 Million EUR | 0.0% |
| 2005 FY | 149.66 Million EUR | 31.58% |
| 2005 Q1 | 37.41 Million EUR | 31.58% |
| 2005 Q4 | 37.41 Million EUR | 0.0% |
| 2005 Q3 | 37.41 Million EUR | 0.0% |
| 2004 Q1 | 28.43 Million EUR | 9.56% |
| 2004 Q4 | 28.43 Million EUR | 0.0% |
| 2004 Q2 | 28.43 Million EUR | 0.0% |
| 2004 Q3 | 28.43 Million EUR | 0.0% |
| 2004 FY | 113.74 Million EUR | 9.56% |
| 2003 Q2 | 25.95 Million EUR | 0.0% |
| 2003 Q4 | 25.95 Million EUR | 0.0% |
| 2003 FY | 103.81 Million EUR | 9.29% |
| 2003 Q1 | 25.95 Million EUR | 9.29% |
| 2003 Q3 | 25.95 Million EUR | 0.0% |
| 2002 FY | 94.99 Million EUR | 0.0% |
| 2002 Q2 | 23.74 Million EUR | 0.0% |
| 2002 Q3 | 23.74 Million EUR | 0.0% |
| 2002 Q4 | 23.74 Million EUR | 0.0% |
| 2002 Q1 | 23.74 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Biosynex SA | 49.13 Million EUR | -1162.721% |
| Predilife S.A. | 306.88 Thousand EUR | -202060.418% |
| bioMérieux S.A. | 1.88 Billion EUR | 67.117% |
| Lumibird SA | 17.25 Million EUR | -3495.48% |